OBERLAND CAPITAL MANAGEMENT LLC

{{ Info.Overview }}
Revenue: {{ Info.Revenue | formatUSD }} Headquarters: {{ Info.Headquarters }}
{{ Info.Homepage }}

Adviser Profile

As of Date:

03/29/2024

Adviser Type:

- Large advisory firm

Number of Employees:

27 22.73%

of those in investment advisory functions:

19 26.67%

Registration:

SEC, Approved, 4/6/2015

Other registrations (1)
AUM:

3,120,630,599 -6.35%

of that, discretionary:

3,120,630,599 -6.35%

GAV:

3,120,630,599 -6.35%

Avg Account Size:

173,368,367 -6.35%

SMA’s:

NO

Private Funds:

8

Contact Info

212 xxxxxxx

Websites :
Client Types:

+

Advisory Activities:

+

Compensation Arrangments:

+

Reported AUM

Discretionary
Non-discretionary
3B 3B 2B 2B 1B 952M 476M
2015 2016 2017 2018 2019 2020 2021 2022 2023

Recent News

ImmunityBio announces $320M investment by Oberland Capital
01/02/2024

Seeking Alpha

Arizona Public Safety plan makes commitment to Oberland Capital fund
10/27/2022

As of Aug. 31, the pension fund's actual allocation to private credit was 11.4%; the target is 20%. PSPRS spokesman Christian Palmer did not reply to ...

pionline.com

Zealand Pharma, Oberland Capital amend financing contract
05/10/2022

Seeking Alpha

Zealand Pharma amends existing financing agreement with Oberland Capital
05/10/2022

Seeking Alpha

Zealand Pharma inks 7-year, $200M financing deal with Oberland Capital
12/14/2021

Seeking Alpha

Oxford BioMedica refinances debt
04/06/2021

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

investorschronicle.co.uk


Private Funds Structure

Fund Type Count GAV
Hedge Fund 1 $6,012,345
Private Equity Fund 7 $3,114,618,254

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM # funds
VR ADVISER, LLC 1.5b - 1.4b - - - - 2.9b 2.9b 8
VECTOR CAPITAL MANAGEMENT, L.P. 512.9m - 3.5b - - - - 4.0b 4.1b 8
TEKNE CAPITAL MANAGEMENT, LLC 510.0m - 546.3m - - - - 1.1b 1.1b 15
SOFTVEST ADVISORS, LLC 473.6m - 54.7m - - - - 528.3m 544.2m 6
SUN CAPITAL ADVISORS, L.P. 15.7m - 6.6b - - - - 6.6b 6.6b 15
CORSAIR CAPITAL LLC 1.2b - 5.1b - - - - 6.2b 8.4b 47
BURFORD CAPITAL INVESTMENT MANAGEMENT LLC - - 3.4b - - - - 3.4b 3.4b 12
RRG CAPITAL MANAGEMENT LLC 296.7m - 1.5b - - - - 1.8b 2.5b 8
SAGEVIEW CAPITAL LP 19.5m - 1.6b - - - - 1.6b 2.1b 7
GRATUS CAPITAL, LLC 19.2m - 141.0m - - - - 160.1m 2.7b 7

Private Funds



Employees




Brochure Summary

Overview

This Brochure applies to Oberland or the Adviser, which in addition to Oberland Capital Management LLC, includes its relying adviser QuantBio Management LLC (the “Relying Adviser”). Oberland Capital Management LLC, a Delaware limited liability company, began operations in 2013. QuantBio Management LLC, a Delaware limited liability company began operations in 2022. Oberland’s business consists of providing advisory services on behalf of pooled investment vehicles (collectively the “Funds”) that focus on investments in the healthcare sector (“Portfolio Investments”). The Funds are exempt from registration under the Investment Company Act of 1940, as amended (the “1940 Act”), and the securities of the Funds are not registered under the Securities Act of 1933, as amended (the “Securities Act”). The Funds advised by Oberland Capital Management LLC primarily make investments in traditional and structured royalties in the healthcare products industry (such Funds, the “Oberland Capital Funds”). The Funds advised by the Relying Adviser primarily make investments in the listed equities of publicly-traded
pharmaceutical, biotechnology and other companies in the healthcare sector (such Funds, the “QuantBio Funds”). Oberland’s advisory services consist of investigating, identifying and evaluating investment opportunities, structuring, negotiating and making investments on behalf of the Funds, managing and monitoring the performance of such investments and disposing of such investments. Oberland provides investment supervisory services to each Fund in accordance with the limited partnership agreement (or analogous organizational document) of such Fund or separate investment and advisory, investment management or portfolio management agreements. Investment advice is provided directly to the Funds, subject to the discretion and control of the applicable general partner, and not individually to the investors in the Funds. Each of Oberland Capital Management LLC and QuantBio Management LLC is owned by Mr. Andrew Rubenstein and Mr. Jean-Pierre Naegeli. As of December 31, 2022, Oberland Capital Management LLC had approximately $3.3 billion in assets under management, all of which is discretionary.